HIV and AIDS Malignancy Research Fellowship


About:

This advanced fellowship program is designed for physicians who have completed specialty training in hematology and/or oncology and want to gain specialized training in clinical and translational research in human immunodeficiency virus (HIV) and/or virus-associated malignancies. It is most suited for individuals who are pursuing an academic career in this field, either in the United States or in international settings. Investigators may engage in basic laboratory research, preclinical studies, translational research and clinical trials. Learn more...


Fellowship Director

Kathryn Lurain, MD, MPH
HIV and AIDS Malignancy Branch
Ph: 240.858.3257

Associate Director:

Robert Yarchoan, MD
Chief, HIV and AIDS Malignancy Branch
Ph: 240.760.6075


How to Apply:

Candidates should have ACGME-accredited board certification in pediatrics or internal medicine plus relevant subspecialty training (usually, but not limited to, oncology or hematology). While this is not an absolute requirement, exceptions will be made only for candidates who have a strong academic background in relevant areas. Physicians with a strong background in laboratory research but without the above credentials may apply to individual laboratories within the HIV and AIDS Malignancy Branch for training in laboratory research.

Candidates may apply directly to Robert Yarchoan, MD.

This program is part of Graduate Medical Education at NIH.

Training at the NIH Clinical Center

All CCR residents and clinical fellows train at the 240-bed NIH Clinical Center in Bethesda, Maryland. The Clinical Center is internationally recognized as the premier hospital dedicated to translational research and clinical care. Elective rotations offer residents and clinical fellows the opportunity to have direct experience in the care of patients enrolled in investigational protocols in the disciplines of allergy and immunology, anatomic pathology, critical care medicine/internal medicine, hematopathology, infectious diseases, medical genetics, and transfusion medicine. Participants will have first-hand exposure to the design, conduct, and management of clinical trials.